Annexon, Inc. (ANNX) vs Rigel Pharmaceuticals, Inc. (RIGL)
- Annexon, Inc. ANNX 4.01 −4.30%
- Rigel Pharmaceuticals, Inc. RIGL 45.04 +1.17%
Annexon, Inc. and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. Annexon, Inc. and Rigel Pharmaceuticals, Inc. are of similar size ($838.3M and $794.3M). Annexon, Inc. has negative trailing earnings, so its P/E is not meaningful; Rigel Pharmaceuticals, Inc. trades at 2.6×. Rigel Pharmaceuticals, Inc. has the higher net margin (106.6% vs 0.00%) and the higher return on invested capital (13.7% vs 0.00%). Across the 14 metrics below, Rigel Pharmaceuticals, Inc. leads on 13 and Annexon, Inc. on 1.
Valuation
Profitability
| Metric | ANNX | RIGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 89.64% | 68.81% |
| Operating margin | 0.00% | 26.28% | 0.00% |
| Net margin | 0.00% | 106.59% | 0.00% |
| Free cash flow margin | 0.00% | 6.72% | 0.00% |
| Return on equity | (130.80%) | 109.18% | (50.30%) |
| Return on assets | (82.98%) | 80.16% | (45.47%) |
| Return on invested capital | 0.00% | 13.69% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack